Initial real life experience with ribociclib in breast cancer: Outcome with focus on tolerance and cardiac toxicity

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2021
This article has no abstract
Epistemonikos ID: a59f6b63c90717b582022b9b1f046b9b9ef77398
First added on: Feb 13, 2025